FDA approves new drug for irritable bowel syndrome and constipation

Author(s):

On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation in adults. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here